학술논문
Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report
Document Type
article
Author
Source
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 4, Pp 373-375 (2020)
Subject
Language
English
ISSN
2531-1379